Vor Biopharma competitorsClear all

Vor Biopharma's top competitors include NextCure, Celgene and Arvinas.
Vor Biopharma
Vor Biopharma
Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer.
NextCure
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Celgene
Celgene
Celgene Corporation is a biopharmaceutical company.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Founding Date
Founding Date
2016
Founding Date
2015
Founding Date
1986
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Boston, US HQ
Locations
Beltsville, US HQ
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
New Haven, US HQ
Employees
Employees
5
Employees
N/A
Employees
N/A
Employees
10311% increase
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
26.7 k
Twitter followers
1.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
15.8
Average likes per tweet (last 30 days)
2.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
394956
Alexa Website Rank
955378
Alexa Website Rank
315342
Alexa Website Rank
396803

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
$14.3m (FY, 2018)
Net income
Net income
N/A
Net income
($22.8m) (FY, 2018)
Net income
$4b (FY, 2018)
Net income
($41.5m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 42m
Total funding raised
$ 160m
Total funding raised
N/A
Total funding raised
$ 111.6m
For sources of this data, please see the company profile

View company profiles

NextCure
HQ
Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

View company
Celgene
HQ
Summit, US

Celgene Corporation is a biopharmaceutical company.

View company
Arvinas
HQ
New Haven, US
Employees
103↑ 11% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company